238 related articles for article (PubMed ID: 9788400)
1. Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study.
Bensadoun RJ; Etienne MC; Dassonville O; Chauvel P; Pivot X; Marcy PY; Prevost B; Coche-Dequeant B; Bourdin S; Vallicioni J; Poissonnet G; Courdi A; Teissier E; Lagrange JL; Thyss A; Santini J; Demard F; Schneider M; Milano G
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):237-45. PubMed ID: 9788400
[TBL] [Abstract][Full Text] [Related]
2. [Concomitant bifractionated radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in locally progressive, non-resectable epidermoid carcinomas of the pharynx: ten years experience at the Antoine Lacassagne center].
Magné N; Pivot X; Marcy PY; Chauvel P; Courdi A; Dassonville O; Poissonnet G; Vallicioni J; Ettore F; Falewee MN; Milano G; Santini J; Lagrange JL; Schneider M; Demard F; Bensadoun RJ
Cancer Radiother; 2001 Aug; 5(4):413-24. PubMed ID: 11521390
[TBL] [Abstract][Full Text] [Related]
3. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).
Bensadoun RJ; Bénézery K; Dassonville O; Magné N; Poissonnet G; Ramaïoli A; Lemanski C; Bourdin S; Tortochaux J; Peyrade F; Marcy PY; Chamorey E; Vallicioni J; Seng H; Alzieu C; Géry B; Chauvel P; Schneider M; Santini J; Demard F; Calais G
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):983-94. PubMed ID: 16376489
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
Schneider M; Etienne MC; Milano G; Thyss A; Otto J; Dassonville O; Mobayen H; Saudes L; Guillot T; Demard F
J Clin Oncol; 1995 Jul; 13(7):1656-62. PubMed ID: 7602355
[TBL] [Abstract][Full Text] [Related]
5. Concomitant twice-a-day radiotherapy and chemotherapy in unresectable head and neck cancer patients: A long-term quality of life analysis.
Magné N; Marcy PY; Chamorey E; Guardiola E; Pivot X; Schneider M; Demard F; Bensadoun RJ
Head Neck; 2001 Aug; 23(8):678-82. PubMed ID: 11443751
[TBL] [Abstract][Full Text] [Related]
6. Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinoma.
Kutter J; Ozsahin M; Monnier P; Stupp R
Eur Arch Otorhinolaryngol; 2005 Jan; 262(1):1-7. PubMed ID: 15004704
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.
Wendt TG; Grabenbauer GG; Rödel CM; Thiel HJ; Aydin H; Rohloff R; Wustrow TP; Iro H; Popella C; Schalhorn A
J Clin Oncol; 1998 Apr; 16(4):1318-24. PubMed ID: 9552032
[TBL] [Abstract][Full Text] [Related]
9. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.
Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R
Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276
[TBL] [Abstract][Full Text] [Related]
10. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
11. Enhanced acute toxicity in oropharynx carcinoma treated with radiotherapy and concomitant cisplatin, 5-fluorouracil and mitomycin C.
Berger C; Chapet S; Reynaud-Bougnoux A; Garand G; Le Floch O; Calais G
Eur J Cancer; 1996 Sep; 32A(10):1707-11. PubMed ID: 8983278
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy in locoregionally advanced carcinoma of the oropharynx.
Fallai C; Bolner A; Signor M; Gava A; Franchin G; Ponticelli P; Taino R; Rossi F; Ardizzoia A; Oggionni M; Crispino S; Olmi P
Tumori; 2006; 92(1):41-54. PubMed ID: 16683383
[TBL] [Abstract][Full Text] [Related]
13. Weekly low-dose docetaxel-based chemoradiotherapy for locally advanced oropharyngeal or hypopharyngeal carcinoma: a retrospective, single-institution study.
Fukada J; Shigematsu N; Takeda A; Ohashi T; Tomita T; Shiotani A; Kunieda E; Kawaguchi O; Fujii M; Kubo A
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):417-24. PubMed ID: 19409727
[TBL] [Abstract][Full Text] [Related]
14. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.
Staar S; Rudat V; Stuetzer H; Dietz A; Volling P; Schroeder M; Flentje M; Eckel HE; Mueller RP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1161-71. PubMed ID: 11483325
[TBL] [Abstract][Full Text] [Related]
15. [Concurrent chemoradiotherapy for squamous cell carcinoma of the oropharynx].
Kubota A; Furukawa M; Hanamura H; Fujita Y; Sugiyama M
Nihon Jibiinkoka Gakkai Kaiho; 2007 Sep; 110(9):635-42. PubMed ID: 17966498
[TBL] [Abstract][Full Text] [Related]
16. [Concomitant radiochemotherapy with cisplatin (CDDP), 5-fluorouracil (5-FU) and mitomycin C (MMC) in locally advanced carcinoma of the oropharynx. Results of a phase II trial].
Berger C; Chapet S; Calais G; Reynaud-Bougnoux A; Garand G; le Floch O
Bull Cancer; 1995 Dec; 82(12):1044-51. PubMed ID: 8745671
[TBL] [Abstract][Full Text] [Related]
17. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.
Merlano M; Benasso M; Corvò R; Rosso R; Vitale V; Blengio F; Numico G; Margarino G; Bonelli L; Santi L
J Natl Cancer Inst; 1996 May; 88(9):583-9. PubMed ID: 8609658
[TBL] [Abstract][Full Text] [Related]
18. [Accelerated hyperfractionated radiotherapy combined with simultaneous chemotherapy in locally advanced pharyngeal and oral carcinomas].
Stuschke M; Budach V; Dinges S; Jahnke K; Budach W; Heselmann I; Unger A; Stüben G; Sack H
Strahlenther Onkol; 1994 Dec; 170(12):689-99. PubMed ID: 7817270
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy rapidly alternating with accelerated radiotherapy for advanced carcinomas of the hypopharynx and upper esophagus: a feasibility study.
Vikram B; Malamud S; Gold J; Nussbaum M; Kimmelman C; Lucente F; Pavlou W; Pisch J; Chadha M; Beattie E
Head Neck; 1991; 13(5):415-9. PubMed ID: 1938358
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.
Herchenhorn D; Dias FL; Viegas CM; Federico MH; Araújo CM; Small I; Bezerra M; Fontão K; Knust RE; Ferreira CG; Martins RG
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):696-702. PubMed ID: 20421154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
